# Stevanato Group S.p.A. (STVN)

Source: https://www.quantisnow.com/company/STVN
Generated: 2026-11-12T16:06:42.229Z

- Ticker: STVN
- Exchange: NYSE
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2021
- SEC CIK: 0001849853
- Website: stevanatogroup.com

## About

Stevanato Group S.p.A. engages in the design, production, and distribution of products and systems to provide integrated solutions for pharma and healthcare. Its principal products are linked to containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machine. Stevanato Group S.p.A. was founded in 1949 and is based in Piombino Dese, Italy.

## Latest STVN news and filings

- 2026-11-10 21:30 UTC [Insider Buy] [Director Morel Donald E Jr bought $326,750 worth of Ordinary Shares (25,000 units at $13.07), increasing direct ownership by 67% to 62,424 units (SEC Form 4)](https://www.quantisnow.com/insight/director-morel-donald-e-jr-bought-326750-worth-of-ordinary-6784346)
- 2026-11-04 16:06 UTC [Analyst Downgrade] [Stevanato Group S.p.A. downgraded by William Blair](https://www.quantisnow.com/insight/stevanato-group-spa-downgraded-by-william-blair-6771844)
- 2026-11-03 21:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by Stevanato Group S.p.A.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-stevanato-group-spa-6769816)
- 2026-11-03 21:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Stevanato Group S.p.A.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-stevanato-group-spa-6769685)
- 2026-11-03 21:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Stevanato Group S.p.A.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-stevanato-group-spa-6769537)
- 2026-11-03 11:30 UTC [Earnings] [Stevanato Group Delivers 8% Revenue Growth for the Third Quarter of Fiscal 2026](https://www.quantisnow.com/insight/stevanato-group-delivers-8-revenue-growth-for-the-third-quarter-6768262)
- 2026-10-27 11:00 UTC [Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection](https://www.quantisnow.com/insight/stevanato-group-and-aptar-pharma-collaborate-to-help-accelerate-pre-filled-6758417)
- 2026-10-20 20:30 UTC [Earnings Date] [Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026](https://www.quantisnow.com/insight/stevanato-group-to-report-third-quarter-2026-financial-results-on-6752282)
- 2026-10-07 11:59 UTC [Analyst Coverage Initiated] [Deutsche Bank initiated coverage on Stevanato Group S.p.A.](https://www.quantisnow.com/insight/deutsche-bank-initiated-coverage-on-stevanato-group-spa-6739711)
- 2026-09-30 21:20 UTC [SEC Form 4] [Officer Stocchi Mauro sold $293,454 worth of Ordinary Shares (13,649 units at $21.50), decreasing direct ownership by 3% to 400,000 units (SEC Form 4)](https://www.quantisnow.com/insight/officer-stocchi-mauro-sold-293454-worth-of-ordinary-shares-13649-6730974)
- 2026-09-09 12:39 UTC [Analyst Coverage Initiated] [UBS initiated coverage on Stevanato Group S.p.A.](https://www.quantisnow.com/insight/ubs-initiated-coverage-on-stevanato-group-spa-6709480)
- 2026-09-08 20:05 UTC [Conference Announcement] [Stevanato Group to Participate in Two Upcoming Investor Conferences](https://www.quantisnow.com/insight/stevanato-group-to-participate-in-two-upcoming-investor-conferences-6708217)
- 2026-08-13 20:30 UTC [SEC Form SCHEDULE 13G filed by Stevanato Group S.p.A.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-stevanato-group-spa-6680856)
- 2026-08-10 20:15 UTC [SEC Form 4] [Director Magistretti Elisabetta sold $41,084 worth of Ordinary Shares (2,045 units at $20.09), decreasing direct ownership by 41% to 2,930 units (SEC Form 4) to cover taxes](https://www.quantisnow.com/insight/director-magistretti-elisabetta-sold-41084-worth-of-ordinary-shares-2045-6673819)
- 2026-08-10 20:15 UTC [SEC Form 4] [Chief Financial Officer Dal Lago Marco sold $84,559 worth of Ordinary Shares (4,209 units at $20.09), decreasing direct ownership by 5% to 81,144 units (SEC Form 4) to cover withholding tax](https://www.quantisnow.com/insight/chief-financial-officer-dal-lago-marco-sold-84559-worth-of-6673818)
- 2026-08-10 20:15 UTC [SEC Form 4] [Director Santel Luciano sold $40,642 worth of Ordinary Shares (2,023 units at $20.09), decreasing direct ownership by 30% to 4,739 units (SEC Form 4) (withholding tax)](https://www.quantisnow.com/insight/director-santel-luciano-sold-40642-worth-of-ordinary-shares-2023-6673817)
- 2026-08-06 20:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Stevanato Group S.p.A.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-stevanato-group-spa-6668505)
- 2026-08-04 20:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by Stevanato Group S.p.A.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-stevanato-group-spa-6662364)
- 2026-08-04 20:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Stevanato Group S.p.A.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-stevanato-group-spa-6662221)
- 2026-08-04 20:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Stevanato Group S.p.A.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-stevanato-group-spa-6662040)
- 2026-08-04 19:39 UTC [SEC Form SCHEDULE 13G filed by Stevanato Group S.p.A.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-stevanato-group-spa-6661815)
- 2026-08-04 10:30 UTC [Earnings] [Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026](https://www.quantisnow.com/insight/stevanato-group-delivers-8-revenue-growth-for-the-second-quarter-6660809)
- 2026-07-30 10:30 UTC [Public Offering] [Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries](https://www.quantisnow.com/insight/liraglutide-combination-products-incorporating-stevanato-groups-alina-pen-injector-received-6654707)
- 2026-07-21 10:30 UTC [Earnings Date] [Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026](https://www.quantisnow.com/insight/stevanato-group-to-report-second-quarter-2026-financial-results-on-6643071)
- 2026-06-26 10:18 UTC [SEC Form 4] [Director Balachandran Madhavan was granted 4,975 units of Ordinary Shares and sold $25,515 worth of Ordinary Shares (1,493 units at $17.09), increasing direct ownership by 5% to 69,458 units (SEC Form 4) to satisfy withholding obligation](https://www.quantisnow.com/insight/director-balachandran-madhavan-was-granted-4975-units-of-ordinary-shares-6616657)
- 2026-06-26 10:16 UTC [SEC Form 4] [Chief Financial Officer Dal Lago Marco was granted 2,356 units of Ordinary Shares and converted options into 7,997 units of Ordinary Shares, increasing direct ownership by 14% to 85,353 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-dal-lago-marco-was-granted-2356-units-6616655)
- 2026-06-26 10:14 UTC [SEC Form 4] [Director Lin Sue-Jean was granted 4,975 units of Ordinary Shares, increasing direct ownership by 249% to 6,975 units (SEC Form 4)](https://www.quantisnow.com/insight/director-lin-sue-jean-was-granted-4975-units-of-ordinary-shares-6616650)
- 2026-06-26 10:12 UTC [SEC Form 4] [Director Morel Donald E Jr was granted 4,975 units of Ordinary Shares and sold $25,515 worth of Ordinary Shares (1,493 units at $17.09), increasing direct ownership by 10% to 37,424 units (SEC Form 4) (tax withholding)](https://www.quantisnow.com/insight/director-morel-donald-e-jr-was-granted-4975-units-of-6616647)
- 2026-06-26 10:10 UTC [SEC Form 4] [Director Santel Luciano was granted 4,975 units of Ordinary Shares, increasing direct ownership by 278% to 6,762 units (SEC Form 4)](https://www.quantisnow.com/insight/director-santel-luciano-was-granted-4975-units-of-ordinary-shares-6616644)
- 2026-06-26 10:08 UTC [SEC Form 4] [Director Magistretti Elisabetta was granted 4,975 units of Ordinary Shares (SEC Form 4)](https://www.quantisnow.com/insight/director-magistretti-elisabetta-was-granted-4975-units-of-ordinary-shares-6616642)
- 2026-06-26 10:07 UTC [SEC Form 4] [Officer Stocchi Mauro was granted 2,101 units of Ordinary Shares and converted options into 6,586 units of Ordinary Shares, increasing direct ownership by 2% to 413,629 units (SEC Form 4)](https://www.quantisnow.com/insight/officer-stocchi-mauro-was-granted-2101-units-of-ordinary-shares-6616641)
- 2026-06-26 10:05 UTC [SEC Form 4] [Director Flynn Karen was granted 4,975 units of Ordinary Shares and sold $25,515 worth of Ordinary Shares (1,493 units at $17.09), increasing direct ownership by 153% to 5,757 units (SEC Form 4) (tax withholding)](https://www.quantisnow.com/insight/director-flynn-karen-was-granted-4975-units-of-ordinary-shares-6616639)
- 2026-06-26 10:04 UTC [SEC Form 4] [Director Federici William J was granted 4,975 units of Ordinary Shares and sold $25,515 worth of Ordinary Shares (1,493 units at $17.09), increasing direct ownership by 15% to 26,991 units (SEC Form 4) to satisfy withholding obligation](https://www.quantisnow.com/insight/director-federici-william-j-was-granted-4975-units-of-ordinary-6616636)
- 2026-06-16 12:15 UTC [Analyst Coverage Initiated] [TD Cowen initiated coverage on Stevanato Group S.p.A. with a new price target](https://www.quantisnow.com/insight/td-cowen-initiated-coverage-on-stevanato-group-spa-with-a-6604023)
- 2026-06-08 10:30 UTC [Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management](https://www.quantisnow.com/insight/stevanato-group-introduces-deora-a-pen-injector-for-subcutaneous-delivery-6592429)
- 2026-06-05 20:34 UTC [SEC Form 6-K] [SEC Form 6-K filed by Stevanato Group S.p.A.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-stevanato-group-spa-6591597)
- 2026-06-03 21:45 UTC [Leadership Update] [Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders' Meeting](https://www.quantisnow.com/insight/stevanato-group-announces-results-of-ordinary-and-extraordinary-shareholders-meeting-6587899)
- 2026-06-02 12:38 UTC [Analyst Coverage Resumed] [Wolfe Research resumed coverage on Stevanato Group S.p.A. with a new price target](https://www.quantisnow.com/insight/wolfe-research-resumed-coverage-on-stevanato-group-spa-with-a-6583458)
- 2026-05-29 20:39 UTC [SEC Form SD filed by Stevanato Group S.p.A.](https://www.quantisnow.com/insight/sec-form-sd-filed-by-stevanato-group-spa-6579582)
- 2026-05-15 20:47 UTC [SEC Form 6-K] [SEC Form 6-K filed by Stevanato Group S.p.A.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-stevanato-group-spa-6558112)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/STVN
- Earnings history: https://www.quantisnow.com/earnings/STVN
- Dividend history: https://www.quantisnow.com/dividends/STVN
- Insider transactions: https://www.quantisnow.com/insiders/STVN
- Options chain: https://www.quantisnow.com/options/STVN
- SEC 8-K filings only: https://www.quantisnow.com/company/STVN/8-k
- RSS and alerts for STVN: https://www.quantisnow.com/docs/rss-feeds.md